Detection of the Prevalence of HBV/HCV Coinfection in Anti-HCV-Positive Samples

Creative Commons License

FİDAN I., Cuhadar T., Koc Z., KARAKUŞ R.

KLIMIK JOURNAL, vol.31, no.1, pp.16-19, 2018 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 31 Issue: 1
  • Publication Date: 2018
  • Doi Number: 10.5152/kd.2018.06
  • Journal Name: KLIMIK JOURNAL
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.16-19
  • Keywords: Hepatitis C antibodies, hepatitis B surface antigen, co-infection, HEPATITIS-B-VIRUS, COMBINATION THERAPY, REACTIVATION, INFECTION, PATIENT, HBV, EPIDEMIOLOGY, DACLATASVIR, ASUNAPREVIR, FEATURES
  • Gazi University Affiliated: Yes

Abstract

Objective: Chronic hepatitis is a common cause of liver-related morbidity due to hepatotropic viruses, such as hepatitis B virus (HBV) and hepatitis C virus (HCV). HBV/HCV co-infection leads to more severe liver diseases and increased risk of hepatocellular carcinoma. In addition, hepatitis B virus reactivation has been reported after treatment for chronic hepatitis C in patients with HBV/HCV co-infection. In our study, we aimed to detect the prevalence of HBV/HCV co-infection in anti-HCV-positive samples, retrospectively.